Healthcare Equipment and Supplies
Company Overview of InforMedix Holdings Inc.
InforMedix Holdings, Inc. engages in the development, patenting, and integration of Med-eXpert system, an integrated Internet-based communication system to provide data analytics; and database software platform to monitor patient medication adherence and health status. The company offers a portable patient monitoring device, hardware, software, and networked communications system to enable consumers, pharmacists, health plans, disease management organizations, pharmaceutical and biomedical companies, medical researchers, and physicians to monitor and manage patients’ medication adherence and clinical response. Its products include Med-eMonitor, a portable interactive patient monitoring ‘smar...
5880 Hubbard Drive
Rockville, MD 20852
Founded in 1997
Key Executives for InforMedix Holdings Inc.
Senior Vice President Operations and Direct Sales and Director of Sales
Vice President of Research & Development and Vice President of Research & Development - InforMedix Inc
Compensation as of Fiscal Year 2014.
InforMedix Holdings Inc. Key Developments
SEC Orders Hearings On Registration Suspension Or Revocation Against InforMedix Holdings
Nov 19 13
In conjunction with trading suspension, the Securities and Exchange Commission (SEC or the Commission) also instituted public administrative proceedings to determine whether to revoke or suspend for a period not exceeding twelve months the registration of each class of the securities of InforMedix Holdings, Inc. for failure to make required periodic filings with the Commission. In this Order, the Division of Enforcement (Division) alleges that the company delinquent in their required periodic filings with the Commission. In this proceeding, instituted pursuant to Exchange Act Section 12(j), a hearing will be scheduled before an Administrative Law Judge. At the hearing, the judge will hear evidence from the Division and the company to determine whether the allegations of the Division contained in the Order, which the Division alleges constitute failures to comply with Exchange Act Section 13(a) and Rules 13a-1 and 13a-13 there under, are true. The judge in the proceeding will then determine whether the registrations pursuant to Exchange Act Section 12 of each class of the securities of the company should be revoked or suspended for a period not exceeding twelve months. The Commission ordered that the Administrative Law Judge in this proceeding issue an initial decision not later than 120 days from the date of service of the order instituting proceedings.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries